Coeptis Therapeutics (COEP) Holdings announced it has regained compliance with Listing Rule 5550, as required by the Nasdaq Hearings Panel’s decision of September 17, 2024.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COEP:
- Coeptis Therapeutics Holdings Inc trading resumes
- Coeptis Therapeutics Holdings Inc trading halted, volatility trading pause
- Coeptis Therapeutics Holdings Inc trading halted, news pending
- Upcoming Stock Splits This Week (December 30 to January 3) – Stay Invested
- Coeptis Therapeutics announces 1-for-20 reverse stock split